Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway

被引:290
作者
Miao, H
Wei, BR
Peehl, DM
Li, Q
Alexandrou, T
Schelling, JR
Rhim, JS
Sedor, JR
Burnett, E
Wang, BC
机构
[1] Case Western Reserve Univ, Sch Med, Rammelkamp Ctr Res, Cleveland, OH 44109 USA
[2] Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44109 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44109 USA
[4] Stanford Univ, Dept Urol, Stanford, CA 94305 USA
[5] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/35074604
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interactions between Eph receptor tyrosine kinases (RTKs) and membrane-anchored ephrin ligands critically regulate axon pathfinding and development of the cardiovascular system, as well as migration of neural cells. Similar to other RTKs, ligand-activated Eph kinases recruit multiple signalling and adaptor proteins, several of which are involved in growth regulation(1,2). However, in contrast to other RTKs, activation of Eph receptors fails to promote cell proliferation(3,4) or to transform rodent fibroblasts(5), indicating that Eph kinases may initiate signalling pathways that are distinct from those transmitted by other RTKs. Here we show that stimulation of endogenous EphA kinases with ephrin-A1 potently inhibits the Ras/MAPK cascade in a range of cell types, and attenuates activation of mitogen-activated protein kinase (MAPK) by receptors for platelet-derived growth factor (PDGF), epidermal growth factor (EGF) and Vascular endothelial growth factor (VEGF). In prostatic epithelial cells and endothelial cells, but not fibroblasts, treatment with ephrin-A1 inhibits cell proliferation. Our results identify EphA kinases as negative regulators of the Ras/MAPK pathway that exert anti-mitogenic functions in a cell-type-specific manner.
引用
收藏
页码:527 / 530
页数:4
相关论文
共 50 条
[31]   Genomic structure of the EPHA1 receptor tyrosine kinase gene [J].
Owshalimpur, D ;
Kelley, MJ .
MOLECULAR AND CELLULAR PROBES, 1999, 13 (03) :169-173
[32]   EphA4 receptor tyrosine kinase and regulation of astrocytic gliosis [J].
Goldshmit, V ;
Puschmann, V ;
Galea, M. P. ;
Bartlett, P. F. ;
Turnley, A. M. .
JOURNAL OF NEUROCHEMISTRY, 2007, 102 :161-162
[33]   ephA9, a novel avian receptor tyrosine kinase gene [J].
Sasaki, E ;
Hikono, H ;
Kaku, Y ;
Kuwana, T ;
Naito, M ;
Sakurai, M .
GENE, 2003, 316 :103-110
[34]   Ethanol inhibits insulin receptor tyrosine kinase [J].
Seiler, AEM ;
Henderson, A ;
Rubin, R .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (12) :1869-1872
[35]   Receptor tyrosine kinase dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated colorectal cancer cell lines [J].
Vitiello, P. P. ;
Cardone, C. ;
Ciardiello, D. ;
Barra, G. ;
Matrone, N. ;
Belli, V. ;
Martini, G. ;
Poliero, L. ;
Borrelli, C. ;
Terminiello, M. ;
Troiani, T. ;
Morgillo, F. ;
Ciardiello, F. ;
Martinelli, E. .
ANNALS OF ONCOLOGY, 2018, 29
[36]   The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway [J].
Tajan, Mylene ;
Paccoud, Romain ;
Branka, Sophie ;
Edouard, Thomas ;
Yart, Armelle .
ENDOCRINE REVIEWS, 2018, 39 (05) :676-700
[37]   Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade [J].
Rebecca L Pratt ;
Michael S Kinch .
Oncogene, 2002, 21 :7690-7699
[38]   Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade [J].
Pratt, RL ;
Kinch, MS .
ONCOGENE, 2002, 21 (50) :7690-7699
[39]   Nitric oxide-mediated activation of the Ras-MAP kinase pathway stimulates tyrosine phosphorylation [J].
Monteiro, HP ;
Rocha Oli veira, CJ ;
Ventura, A ;
Stern, A .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 :S355-S355
[40]   Constitutive activation of the Raf–MAPK pathway causes negative feedback inhibition of Ras–PI3K–AKT and cellular arrest through the EphA2 receptor [J].
C W Menges ;
D J McCance .
Oncogene, 2008, 27 :2934-2940